2020
DOI: 10.1136/archdischild-2019-318119
|View full text |Cite
|
Sign up to set email alerts
|

The genetic crystal ball: new answers and new questions for infants with neuromuscular disorders and respiratory failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Specified populations include those with severe neurocognitive disabilities and neuromuscular diseases. For infants with spinal muscular atrophy type‐1, most studies were published before the era of disease‐modifying therapies, 53–57 with limited applicability nowadays 58 . Other populations described as requiring special consideration include children with a vegetative state, multisystem diseases, fully noninvasive ventilation dependent, wards of the state, and those able to participate in decision‐making themselves.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Specified populations include those with severe neurocognitive disabilities and neuromuscular diseases. For infants with spinal muscular atrophy type‐1, most studies were published before the era of disease‐modifying therapies, 53–57 with limited applicability nowadays 58 . Other populations described as requiring special consideration include children with a vegetative state, multisystem diseases, fully noninvasive ventilation dependent, wards of the state, and those able to participate in decision‐making themselves.…”
Section: Resultsmentioning
confidence: 99%
“…For infants with spinal muscular atrophy type-1, most studies were published before the era of disease-modifying therapies, [53][54][55][56][57] with limited applicability nowadays. 58 Other populations described as requiring special consideration include children T A B L E 1 Families-caregivers and healthcare providers' understanding of the pros and cons of tracheostomy that should be considered in decision-making conversations.…”
Section: Special Populationsmentioning
confidence: 99%